Oppenheimer Asset Management Inc. Buys New Position in Itron, Inc. $ITRI

Itron, Inc. (ITRI) experienced notable institutional investor activity in the second quarter, with Oppenheimer Asset Management initiating a new stake and other firms increasing their positions, contributing to 96.19% institutional ownership. The company recently reported Q3 EPS of $1.54, surpassing analyst estimates of $1.48, and revenue of $581.63 million, exceeding the $578.49 million consensus, despite a 5.5% year-over-year revenue decline. Analyst sentiment remains largely positive, with a "Moderate Buy" average rating and an average price target of $139.00, though recent insider selling by two SVPs was also noted.

Analysis

Itron (NASDAQ:ITRI) demonstrated robust institutional interest in Q2, with Oppenheimer Asset Management initiating a new stake of 5,260 shares valued at $692,000, and several other firms significantly increasing their positions, contributing to a high 96.19% institutional ownership. The company reported Q3 EPS of $1.54, exceeding analyst estimates of $1.48, and revenue of $581.63 million, surpassing the $578.49 million consensus, despite a 5.5% year-over-year revenue decline.

Analyst sentiment remains moderately positive, with an average "Moderate Buy" rating and a $139.00 average price target, though individual ratings vary from Roth Capital's $150.00 "buy" to Robert W. Baird's $118.00 "neutral." The stock's current P/E ratio of 17.15 and a PEG ratio of 0.76 suggest a potentially attractive valuation relative to its growth prospects.

However, recent insider selling by two SVPs in August, totaling 3,037 shares valued at $380,566 over 90 days, warrants attention, despite insiders still owning 1.45% of the company. ITRI's opening price of $100.33 is notably below its 50-day ($124.67) and 200-day ($123.10) moving averages, indicating recent price weakness, even as the company projects FY 2025 EPS guidance of $6.84-$6.94.

Key Decisions for Investors

• Investors should evaluate the strong institutional conviction and positive analyst sentiment against the recent insider selling and year-over-year revenue decline.
• Monitor the company's ability to meet its FY 2025 EPS guidance of $6.84-$6.94, as this will be crucial for future stock performance.
• Consider the current stock price relative to its average analyst price target of $139.00 and its valuation metrics (P/E 17.15, PEG 0.76) for potential entry points, while acknowledging recent downward price momentum.